お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:服薬アドヒランスの世界市場 (製品別、薬剤別、地域別):将来展望・産業動向・成長予測 (2030年まで)
市場調査レポート
商品コード
971172

服薬アドヒランスの世界市場 (製品別、薬剤別、地域別):将来展望・産業動向・成長予測 (2030年まで)

Medication Adherence Market Research Report: By Product, Medication - Global Industry Analysis and Growth Forecast to 2030

出版日: | 発行: Prescient & Strategic Intelligence Private Limited | ページ情報: 英文 303 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.22円
服薬アドヒランスの世界市場 (製品別、薬剤別、地域別):将来展望・産業動向・成長予測 (2030年まで)
出版日: 2020年09月01日
発行: Prescient & Strategic Intelligence Private Limited
ページ情報: 英文 303 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の服薬アドヒランスの市場規模は、2019年には23億1000万米ドル、2030年には112億2630万米ドルと、15.5%のCAGRで成長すると予測されています。市場の主な促進要因として、慢性疾患の有病者数の増加や医療費の負担増大が挙げられ、特に新型コロナウイルス感染症 (COVID-19) 感染拡大によりその必要性が高まっています。地域別では、北米諸国が最大の市場となる一方、アジア太平洋諸国での急速な市場成長が見込まれています。

当レポートでは、世界の服薬アドヒランス (服薬遵守) の市場について分析し、システムの概略や背景事情、市場の基本構造や主な市場促進・抑制要因、市場規模の実績値・予測値 (今後11年間分)、製品別・薬剤別 (疾患別)・地域別の詳細動向、市場競争状態、主要企業のプロファイルなどを調査しております。

目次

第1章 分析の背景事情

第2章 分析方法

第3章 エグゼクティブサマリー

  • 業界の専門家/KOLの見解

第4章 イントロダクション

  • 市場区分の定義
    • 製品別
      • ソフトウェア中心
      • ハードウェア中心
    • 薬剤別
      • 心血管
      • 中枢神経系 (CNS)
      • 糖尿病
      • 腫瘍
      • 呼吸器疾患
      • 胃腸
      • リウマチ
      • その他
  • 市場のダイナミクス
    • 市場動向
      • 服薬アドヒランス用アプリの使用拡大
      • 患者用節約プログラムを通じた、服薬アドヒランスに対する意識の高まり
      • 服薬アドヒランスシステムとソフトウェアの人気拡大
    • 促進要因
      • 高度な服薬アドヒランスシステムに対する需要の増大
      • 慢性疾患の有病率の上昇
      • 高齢者人口の増加
      • mヘルス技術の需要増加
      • 個別化医療のニーズの拡大
      • 市場予測に対する促進要因の影響分析
    • 抑制要因
      • 電子カルテ/電子処方箋に基づく服薬アドヒランスシステム:プライバシーやセキュリティの懸念
      • 新興国における不十分な医療インフラ
      • 市場予測に対する抑制要因の影響分析
    • 市場機会
      • 世界各地の広大な未開拓の服薬アドヒランス市場
  • COVID-19が服薬アドヒランス市場に与える影響
    • COVID-19シナリオ
  • ポーターのファイブフォース分析

第5章 世界市場:市場規模と予測

  • 製品別
    • ソフトウェア中心型:種類別
    • ハードウェア中心型:デバイス別
    • ハードウェア中心型:パッケージング別
  • 薬剤別
  • 地域別

第6章 北米市場:市場規模と予測

第7章 欧州市場:市場規模と予測

第8章 アジア太平洋市場:市場規模と予測

第9章 ラテンアメリカ市場:市場規模と予測

第10章 中東・アフリカ市場:市場規模と予測

第11章 主要国の服薬アドヒランス市場

  • 米国市場
    • 製品別
    • 薬剤別
  • カナダ市場
  • ドイツ市場
  • フランス市場
  • スペイン市場
  • 英国市場
  • イタリア市場
  • 日本市場
  • 中国市場
  • インド市場

第12章 服薬アドヒランス製品の分析

  • ハードウェア中心型製品
    • Philips Automated Medication Dispenser
      • 概要
      • 長所
      • 短所
    • 2net Hub
    • Omnicell XT
    • Smart Pill Bottle
    • Nomi Pill Bottle
    • Cardinal Health Repackaging Solutions
    • Dispill
  • ソフトウェア中心型製品
    • RelayRx PriorAuthPlus
    • Adherence Performance Solution
    • eVoucherRx
    • RelayRx Continuity of Care
    • Care4Today
    • Patient Advisor
    • 2net Mobile and 2net Platform
    • Pharmacy Health Connect
    • Prescription Reminder Service - Local Store Marketing
    • Medication Therapy Management Solution
  • 製薬/バイオ医薬品企業が採用した製品・技術
    • スマートピル用ボトル・ボックス・キャップ
    • 人工知能 (AI) ベース製品
    • 直接監視下療法(DOT)の自動化
    • コネクテッド (ネット接続型) デバイス
    • インタラクティブ・ソフトウェア
    • スマート注射器
    • モバイルアプリケーション/ソフトウェア
  • 服薬アドヒランス市場:地域別分析
    • 北米
      • 主な動向
      • 医療制度の市場への影響
      • 予測分析
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
  • 不遵守が臨床試験に与える影響

第13章 競合情勢

  • 主要企業と主力製品/サービスの一覧
  • 主要企業の市場シェア分析
  • 主要企業の相互比較
  • 主要企業の戦略展開状況
    • 製品/サービスの発売
    • パートナーシップ
    • 投資
    • その他の動向

第14章 企業プロファイル

  • Koninklijke Philips N.V.
  • Qualcomm Incorporated
  • AdhereTech Inc.
  • McKesson Corporation
  • Omnicell Inc.
  • SMRxT Inc.
  • DrFirst.com Inc.
  • Cardinal Health Inc.
  • Johnson & Johnson Services Inc.

第15章 付録

図表

LIST OF TABLES

  • TABLE 1 ANALYSIS PERIOD OF THE STUDY
  • TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 4 COVID-19 IMPACT ANALYSIS ON DIFFERENT SECTORS
  • TABLE 5 GLOBAL MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 6 GLOBAL MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 7 GLOBAL SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 8 GLOBAL SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 9 GLOBAL HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2019)
  • TABLE 10 GLOBAL HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2020-2030)
  • TABLE 11 GLOBAL HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2019)
  • TABLE 12 GLOBAL HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2020-2030)
  • TABLE 13 GLOBAL MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2019)
  • TABLE 14 GLOBAL MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2020-2030)
  • TABLE 15 GLOBAL MEDICATION ADHERENCE MARKET, BY REGION, $M (2014-2019)
  • TABLE 16 GLOBAL MEDICATION ADHERENCE MARKET, BY REGION, $M (2020-2030)
  • TABLE 17 NORTH AMERICA MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 18 NORTH AMERICA MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 19 NORTH AMERICA SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 20 NORTH AMERICA SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 21 NORTH AMERICA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2019)
  • TABLE 22 NORTH AMERICA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2020-2030)
  • TABLE 23 NORTH AMERICA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2019)
  • TABLE 24 NORTH AMERICA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2020-2030)
  • TABLE 25 NORTH AMERICA MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2019)
  • TABLE 26 NORTH AMERICA MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2020-2030)
  • TABLE 27 NORTH AMERICA MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 28 NORTH AMERICA MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 29 EUROPE MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 30 EUROPE MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 31 EUROPE SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 32 EUROPE SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 33 EUROPE HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2019)
  • TABLE 34 EUROPE HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2020-2030)
  • TABLE 35 EUROPE HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2019)
  • TABLE 36 EUROPE HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2020-2030)
  • TABLE 37 EUROPE MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2019)
  • TABLE 38 EUROPE MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2020-2030)
  • TABLE 39 EUROPE MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 40 EUROPE MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 41 APAC MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 42 APAC MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 43 APAC SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 44 APAC SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 45 APAC HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2019)
  • TABLE 46 APAC HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2020-2030)
  • TABLE 47 APAC HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2019)
  • TABLE 48 APAC HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2020-2030)
  • TABLE 49 APAC MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2019)
  • TABLE 50 APAC MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2020-2030)
  • TABLE 51 APAC MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 52 APAC MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 53 LATAM MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 54 LATAM MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 55 LATAM SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 56 LATAM SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 57 LATAM HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2019)
  • TABLE 58 LATAM HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2020-2030)
  • TABLE 59 LATAM HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2019)
  • TABLE 60 LATAM HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2020-2030)
  • TABLE 61 LATAM MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2019)
  • TABLE 62 LATAM MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2020-2030)
  • TABLE 63 LATAM MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 64 LATAM MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 65 MEA MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 66 MEA MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 67 MEA SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 68 MEA SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 69 MEA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2019)
  • TABLE 70 MEA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2020-2030)
  • TABLE 71 MEA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2019)
  • TABLE 72 MEA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2020-2030)
  • TABLE 73 MEA MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2019)
  • TABLE 74 MEA MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2020-2030)
  • TABLE 75 MEA MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 76 MEA MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 77 U.S. MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 78 U.S. MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 79 U.S. SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 80 U.S. SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 81 U.S. HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2019)
  • TABLE 82 U.S. HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2020-2030)
  • TABLE 83 U.S. HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2019)
  • TABLE 84 U.S. HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2020-2030)
  • TABLE 85 U.S. MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2019)
  • TABLE 86 U.S. MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2020-2030)
  • TABLE 87 CANADA MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 88 CANADA MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 89 CANADA SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 90 CANADA SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 91 CANADA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2019)
  • TABLE 92 CANADA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2020-2030)
  • TABLE 93 CANADA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2019)
  • TABLE 94 CANADA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2020-2030)
  • TABLE 95 CANADA MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2019)
  • TABLE 96 CANADA MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2020-2030)
  • TABLE 97 GERMANY MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 98 GERMANY MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 99 GERMANY SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 100 GERMANY SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 101 GERMANY HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2019)
  • TABLE 102 GERMANY HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2020-2030)
  • TABLE 103 GERMANY HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2019)
  • TABLE 104 GERMANY HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2020-2030)
  • TABLE 105 GERMANY MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2019)
  • TABLE 106 GERMANY MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2020-2030)
  • TABLE 107 FRANCE MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 108 FRANCE MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 109 FRANCE SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 110 FRANCE SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 111 FRANCE HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2019)
  • TABLE 112 FRANCE HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2020-2030)
  • TABLE 113 FRANCE HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2019)
  • TABLE 114 FRANCE HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2020-2030)
  • TABLE 115 FRANCE MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2019)
  • TABLE 116 FRANCE MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2020-2030)
  • TABLE 117 SPAIN MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 118 SPAIN MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 119 SPAIN SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 120 SPAIN SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 121 SPAIN HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2019)
  • TABLE 122 SPAIN HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2020-2030)
  • TABLE 123 SPAIN HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2019)
  • TABLE 124 SPAIN HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2020-2030)
  • TABLE 125 SPAIN MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2019)
  • TABLE 126 SPAIN MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2020-2030)
  • TABLE 127 U.K. MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 128 U.K. MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 129 U.K. SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 130 U.K. SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 131 U.K. HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2019)
  • TABLE 132 U.K. HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2020-2030)
  • TABLE 133 U.K. HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2019)
  • TABLE 134 U.K. HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2020-2030)
  • TABLE 135 U.K. MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2019)
  • TABLE 136 U.K. MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2020-2030)
  • TABLE 137 ITALY MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 138 ITALY MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 139 ITALY SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 140 ITALY SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 141 ITALY HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2019)
  • TABLE 142 ITALY HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2020-2030)
  • TABLE 143 ITALY HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2019)
  • TABLE 144 ITALY HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2020-2030)
  • TABLE 145 ITALY MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2019)
  • TABLE 146 ITALY MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2020-2030)
  • TABLE 147 JAPAN MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 148 JAPAN MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 149 JAPAN SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 150 JAPAN SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 151 JAPAN HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2019)
  • TABLE 152 JAPAN HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2020-2030)
  • TABLE 153 JAPAN HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2019)
  • TABLE 154 JAPAN HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2020-2030)
  • TABLE 155 JAPAN MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2019)
  • TABLE 156 JAPAN MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2020-2030)
  • TABLE 157 CHINA MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 158 CHINA MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 159 CHINA SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 160 CHINA SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 161 CHINA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2019)
  • TABLE 162 CHINA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2020-2030)
  • TABLE 163 CHINA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2019)
  • TABLE 164 CHINA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2020-2030)
  • TABLE 165 CHINA MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2019)
  • TABLE 166 CHINA MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2020-2030)
  • TABLE 167 INDIA MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2019)
  • TABLE 168 INDIA MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2020-2030)
  • TABLE 169 INDIA SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2019)
  • TABLE 170 INDIA SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2020-2030)
  • TABLE 171 INDIA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2019)
  • TABLE 172 INDIA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2020-2030)
  • TABLE 173 INDIA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2019)
  • TABLE 174 INDIA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2020-2030)
  • TABLE 175 INDIA MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2019)
  • TABLE 176 INDIA MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2020-2030)
  • TABLE 177 LIST OF PLAYERS AND THEIR OFFERINGS
  • TABLE 178 KONINKLIJKE PHILIPS N.V. - AT A GLANCE
  • TABLE 179 KONINKLIJKE PHILIPS N.V. - KEY FINANCIAL SUMMARY
  • TABLE 180 QUALCOMM INCORPORATED - AT A GLANCE
  • TABLE 181 QUALCOMM INCORPORATED - KEY FINANCIAL SUMMARY
  • TABLE 182 ADHERETECH INC. - AT A GLANCE
  • TABLE 183 MCKESSON CORPORATION - AT A GLANCE
  • TABLE 184 MCKESSON CORPORATION - KEY FINANCIAL SUMMARY
  • TABLE 185 OMNICELL INC. - AT A GLANCE
  • TABLE 186 OMNICELL INC. - KEY FINANCIAL SUMMARY
  • TABLE 187 SMRXT INC. - AT A GLANCE
  • TABLE 188 DRFIRST.COM INC. - AT A GLANCE
  • TABLE 189 CARDINAL HEALTH INC. - AT A GLANCE
  • TABLE 190 CARDINAL HEALTH INC. - KEY FINANCIAL SUMMARY
  • TABLE 191 JOHNSON & JOHNSON SERVICES INC. - AT A GLANCE
  • TABLE 192 JOHNSON & JOHNSON SERVICES INC. - KEY FINANCIAL SUMMARY

LIST OF FIGURES

  • FIG 1 RESEARCH SCOPE
  • FIG 2 RESEARCH METHODOLOGY
  • FIG 3 BREAKDOWN OF PRIMARY RESEARCH BY REGION
  • FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT
  • FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE
  • FIG 6 DATA TRIANGULATION APPROACH
  • FIG 7 CURRENCY CONVERSION RATES FOR USD (2019)
  • FIG 8 GLOBAL MEDICATION ADHERENCE MARKET SUMMARY
  • FIG 9 OPINION OF INDUSTRY EXPERTS/KOLS
  • FIG 10 AGING POPULATION AS A PERCENTAGE OF TOTAL REGION POPULATION
  • FIG 11 MAJOR CATEGORIES OF MHEALTH APPLICATIONS AND MEDICATION ADHERENCE
  • FIG 12 PORTER'S FIVE FORCES ANALYSIS
  • FIG 13 GLOBAL MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 14 GLOBAL SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2030)
  • FIG 15 GLOBAL HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2030)
  • FIG 16 GLOBAL HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2030)
  • FIG 17 GLOBAL MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2030)
  • FIG 18 WORLDWIDE MAJOR MARKETS FOR MEDICATION ADHERENCE
  • FIG 19 NORTH AMERICA MEDICATION ADHERENCE MARKET SNAPSHOT
  • FIG 20 NORTH AMERICA MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 21 NORTH AMERICA SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2030)
  • FIG 22 NORTH AMERICA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2030)
  • FIG 23 NORTH AMERICA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2030)
  • FIG 24 NORTH AMERICA MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2030)
  • FIG 25 NORTH AMERICA MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 26 EUROPE MEDICATION ADHERENCE MARKET SNAPSHOT
  • FIG 27 EUROPE MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 28 EUROPE SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2030)
  • FIG 29 EUROPE HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2030)
  • FIG 30 EUROPE HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2030)
  • FIG 31 EUROPE MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2030)
  • FIG 32 EUROPE MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 33 APAC MEDICATION ADHERENCE MARKET SNAPSHOT
  • FIG 34 APAC MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 35 APAC SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2030)
  • FIG 36 APAC HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2030)
  • FIG 37 APAC HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2030)
  • FIG 38 APAC MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2030)
  • FIG 39 APAC MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 40 LATAM MEDICATION ADHERENCE MARKET SNAPSHOT
  • FIG 41 LATAM MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 42 LATAM SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2030)
  • FIG 43 LATAM HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2030)
  • FIG 44 LATAM HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2030)
  • FIG 45 LATAM MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2030)
  • FIG 46 LATAM MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 47 MEA MEDICATION ADHERENCE MARKET SNAPSHOT
  • FIG 48 MEA MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 49 MEA SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2030)
  • FIG 50 MEA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2030)
  • FIG 51 MEA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2030)
  • FIG 52 MEA MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2030)
  • FIG 53 MEA MEDICATION ADHERENCE MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 54 U.S. MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 55 U.S. SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2030)
  • FIG 56 U.S. HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2030)
  • FIG 57 U.S. HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2030)
  • FIG 58 U.S. MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2030)
  • FIG 59 CANADA MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 60 CANADA SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2030)
  • FIG 61 CANADA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2030)
  • FIG 62 CANADA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2030)
  • FIG 63 CANADA MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2030)
  • FIG 64 GERMANY MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 65 GERMANY SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2030)
  • FIG 66 GERMANY HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2030)
  • FIG 67 GERMANY HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2030)
  • FIG 68 GERMANY MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2030)
  • FIG 69 FRANCE MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 70 FRANCE SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2030)
  • FIG 71 FRANCE HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2030)
  • FIG 72 FRANCE HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2030)
  • FIG 73 FRANCE MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2030)
  • FIG 74 SPAIN MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 75 SPAIN SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2030)
  • FIG 76 SPAIN HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2030)
  • FIG 77 SPAIN HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2030)
  • FIG 78 SPAIN MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2030)
  • FIG 79 U.K. MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 80 U.K. SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2030)
  • FIG 81 U.K. HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2030)
  • FIG 82 U.K. HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2030)
  • FIG 83 U.K. MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2030)
  • FIG 84 ITALY MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 85 ITALY SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2030)
  • FIG 86 ITALY HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2030)
  • FIG 87 ITALY HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2030)
  • FIG 88 ITALY MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2030)
  • FIG 89 JAPAN MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 90 JAPAN SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2030)
  • FIG 91 JAPAN HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2030)
  • FIG 92 JAPAN HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2030)
  • FIG 93 JAPAN MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2030)
  • FIG 94 CHINA MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 95 CHINA SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2030)
  • FIG 96 CHINA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2030)
  • FIG 97 CHINA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2030)
  • FIG 98 CHINA MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2030)
  • FIG 99 INDIA MEDICATION ADHERENCE MARKET, BY PRODUCT, $M (2014-2030)
  • FIG 100 INDIA SOFTWARE CENTRIC MEDICATION ADHERENCE MARKET, BY TYPE, $M (2014-2030)
  • FIG 101 INDIA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY DEVICES, $M (2014-2030)
  • FIG 102 INDIA HARDWARE CENTRIC MEDICATION ADHERENCE MARKET, BY PACKAGING, $M (2014-2030)
  • FIG 103 INDIA MEDICATION ADHERENCE MARKET, BY MEDICATION, $M (2014-2030)
  • FIG 104 GLOBAL MEDICATION ADHERENCE MARKET SHARE OF KEY PLAYERS (2019)
  • FIG 105 COMPETITIVE BENCHMARKING OF KEY PLAYERS
  • FIG 106 KONINKLIJKE PHILIPS N.V. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 107 QUALCOMM INCORPORATED - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 108 MCKESSON CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 109 OMNICELL INC. - REVENUE SPLIT BY GEOGRAPHY (2019)
  • FIG 110 CARDINAL HEALTH INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 111 JOHNSON & JOHNSON SERVICES INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
目次
Product Code: LS10138

Title:
Medication Adherence Market Research Report: By Product (Software Centric, Hardware Centric), Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Respiratory, Gastrointestinal, Rheumatology) - Global Industry Analysis and Growth Forecast to 2030.

Every year, cardiovascular diseases kill 17.9 million people, while cancer claims 9.6 million human victims. These statistics by the World Health Organization (WHO) clearly reflect the burden of chronic diseases, which continues to rise. As a result, the global medication adherence market, which generated $2,310.0 million in 2019, is predicted to grow at a robust 15.5% CAGR between 2020 and 2030, to reach $11,226.3 million in 2030, according to P&S Intelligence.

All chronic diseases require prolonged treatment, medication, and monitoring and strict adherence to the medication schedule. The increasing awareness about taking medication as and when directed is the key reason behind the medication adherence market advance. Non-adherence or poor adherence to the medication schedule adds $177 billion to the global healthcare expenditure and results in 25% of all hospitalizations and 50% of all treatment failures each year.

During the COVID-19 pandemic, the medication adherence market is receiving a boost, majorly due to the rapidly rising case and death count attributed to this viral infection. Out of fear of contracting the infection and dying of it due to poor medication adherence, people are rapidly adopting medication adherence solutions. As per a study done on 7,578 patients using controller inhalers, as well as the Propeller Health medication adherence solution, medication adherence rate rose by 14.9% between the first seven days of January 2020 and the last seven days of March 2020.

North America is the most productive region in the medication adherence market presently. As per the CDC, seven in every 10 deaths in the U.S. in 2019 were because of chronic diseases. Apart from the rising prevalence of such medical issues, the geriatric population, healthcare expenditure, and R&D spending on healthcare technologies are increasing in the region. The rising geriatric population is leading to the increasing incidence of chronic diseases, thereby driving the demand for medication adherence solutions.

Over the next 10 years, the medication adherence market will observe the highest CAGR in the Asia-Pacific (APAC) region. The increasing disposable income of the population here is allowing them to go for expensive treatments, as well as medication adherence solutions. Moreover, market players in the region are bringing about technological enhancements in these solutions, for bettering the treatment outcomes. Numerous initiatives have been taken to technologically enhance these solutions, such as those currently underway in Australia and Singapore.

The major companies in the global medication adherence market are: Qualcomm Incorporated, Koninklijke Philips N.V., McKesson Corporation, AdhereTech Inc., SMRxT Inc., Omnicell Inc., Cardinal Health Inc., DrFirst.com Inc., and Johnson & Johnson Services Inc.

Table of Contents

Chapter 1. Research Background

  • 1.1 Research Objectives
  • 1.2 Market Definition
  • 1.3 Research Scope
    • 1.3.1 Market Segmentation by Product
    • 1.3.2 Market Segmentation by Medication
    • 1.3.3 Market Segmentation by Region
    • 1.3.4 Analysis Period
    • 1.3.5 Market Data Reporting Unit
      • 1.3.5.1 Value
  • 1.4 Key Stakeholders

Chapter 2. Research Methodology

  • 2.1 Secondary Research
    • 2.1.1 Paid
    • 2.1.2 Unpaid
  • 2.2 Primary Research
    • 2.2.1 Breakdown of Primary Research Respondents
      • 2.2.1.1 By region
      • 2.2.1.2 By industry participant
      • 2.2.1.3 By company type
  • 2.3 Market Size Estimation
  • 2.4 Data Triangulation
  • 2.5 Currency Conversion Rates
  • 2.6 Assumptions for the Study

Chapter 3. Executive Summary

  • 3.1 Voice of Industry Experts/KOLs

Chapter 4. Introduction

  • 4.1 Definition of Market Segments
    • 4.1.1 By Product
      • 4.1.1.1 Software centric
        • 4.1.1.1.1 Mobile apps
        • 4.1.1.1.2 Others
      • 4.1.1.2 Hardware centric
        • 4.1.1.2.1 Devices
        • 4.1.1.2.1.1 Automated dispensing systems
        • 4.1.1.2.1.2 Smart pill bottles
        • 4.1.1.2.1.3 Electronic trays
        • 4.1.1.2.1.4 Others
        • 4.1.1.2.2 Packaging
        • 4.1.1.2.2.1 Multi dose
        • 4.1.1.2.2.2 Unit dose
    • 4.1.2 By Medication
      • 4.1.2.1 Cardiovascular
      • 4.1.2.2 CNS
      • 4.1.2.3 Diabetes
      • 4.1.2.4 Oncology
      • 4.1.2.5 Respiratory
      • 4.1.2.6 Gastrointestinal
      • 4.1.2.7 Rheumatology
      • 4.1.2.8 Others
  • 4.2 Market Dynamics
    • 4.2.1 Trends
      • 4.2.1.1 Increasing use of medication adherence apps
      • 4.2.1.2 Rising awareness for medication adherence through patient saving programs
      • 4.2.1.3 Growing popularity of medication adherence systems and software
    • 4.2.2 Drivers
      • 4.2.2.1 Growing demand for advanced medication adherence systems
      • 4.2.2.2 Increasing prevalence of chronic diseases
      • 4.2.2.3 Rising geriatric population
      • 4.2.2.4 Increasing demand for mHealth technologies
      • 4.2.2.5 Expanding demand for personalized healthcare
      • 4.2.2.6 Impact analysis of drivers on market forecast
    • 4.2.3 Restraints
      • 4.2.3.1 Privacy and security concerns in the EHR and e-prescribing-based medication adherence systems
      • 4.2.3.2 Inadequate healthcare infrastructure in developing economies
      • 4.2.3.3 Impact analysis of restraints on market forecast
    • 4.2.4 Opportunities
      • 4.2.4.1 Vast unexplored medication adherence market across the globe
  • 4.3 Impact of COVID-19 on Medication Adherence Market
    • 4.3.1 COVID-19 Scenario
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Buyers
    • 4.4.2 Bargaining Power of Suppliers
    • 4.4.3 Intensity of Rivalry
    • 4.4.4 Threat of New Entrants
    • 4.4.5 Threat of Substitutes

Chapter 5. Global Market Size and Forecast

  • 5.1 By Product
    • 5.1.1 Software Centric Medication Adherence Market, by Type
    • 5.1.2 Hardware Centric Medication Adherence Market, by Devices
    • 5.1.3 Hardware Centric Medication Adherence Market, by Packaging
  • 5.2 By Medication
  • 5.3 By Region

Chapter 6. North America Market Size and Forecast

  • 6.1 By Product
    • 6.1.1 Software Centric Medication Adherence Market, by Type
    • 6.1.2 Hardware Centric Medication Adherence Market, by Devices
    • 6.1.3 Hardware Centric Medication Adherence Market, by Packaging
  • 6.2 By Medication
  • 6.3 By Country

Chapter 7. Europe Market Size and Forecast

  • 7.1 By Product
    • 7.1.1 Software Centric Medication Adherence Market, by Type
    • 7.1.2 Hardware Centric Medication Adherence Market, by Devices
    • 7.1.3 Hardware Centric Medication Adherence Market, by Packaging
  • 7.2 By Medication
  • 7.3 By Country

Chapter 8. APAC Market Size and Forecast

  • 8.1 By Product
    • 8.1.1 Software Centric Medication Adherence Market, by Type
    • 8.1.2 Hardware Centric Medication Adherence Market, by Devices
    • 8.1.3 Hardware Centric Medication Adherence Market, by Packaging
  • 8.2 By Medication
  • 8.3 By Country

Chapter 9. LATAM Market Size and Forecast

  • 9.1 By Product
    • 9.1.1 Software Centric Medication Adherence Market, by Type
    • 9.1.2 Hardware Centric Medication Adherence Market, by Devices
    • 9.1.3 Hardware Centric Medication Adherence Market, by Packaging
  • 9.2 By Medication
  • 9.3 By Country

Chapter 10. MEA Market Size and Forecast

  • 10.1 By Product
    • 10.1.1 Software Centric Medication Adherence Market, by Type
    • 10.1.2 Hardware Centric Medication Adherence Market, by Devices
    • 10.1.3 Hardware Centric Medication Adherence Market, by Packaging
  • 10.2 By Medication
  • 10.3 By Country

Chapter 11. Major Markets for Medication Adherence

  • 11.1 U.S. Medication Adherence Market
    • 11.1.1 By Product
      • 11.1.1.1 Software centric medication adherence market, by type
      • 11.1.1.2 Hardware centric medication adherence market, by devices
      • 11.1.1.3 Hardware centric medication adherence market, by packaging
    • 11.1.2 By Medication
  • 11.2 Canada Medication Adherence Market
    • 11.2.1 By Product
      • 11.2.1.1 Software centric medication adherence market, by type
      • 11.2.1.2 Hardware centric medication adherence market, by devices
      • 11.2.1.3 Hardware centric medication adherence market, by packaging
    • 11.2.2 By Medication
  • 11.3 Germany Medication Adherence Market
    • 11.3.1 By Product
      • 11.3.1.1 Software centric medication adherence market, by type
      • 11.3.1.2 Hardware centric medication adherence market, by devices
      • 11.3.1.3 Hardware centric medication adherence market, by packaging
    • 11.3.2 By Medication
  • 11.4 France Medication Adherence Market
    • 11.4.1 By Product
      • 11.4.1.1 Software centric medication adherence market, by type
      • 11.4.1.2 Hardware centric medication adherence market, by devices
      • 11.4.1.3 Hardware centric medication adherence market, by packaging
    • 11.4.2 By Medication
  • 11.5 Spain Medication Adherence Market
    • 11.5.1 By Product
      • 11.5.1.1 Software centric medication adherence market, by type
      • 11.5.1.2 Hardware centric medication adherence market, by devices
      • 11.5.1.3 Hardware centric medication adherence market, by packaging
    • 11.5.2 By Medication
  • 11.6 U.K. Medication Adherence Market
    • 11.6.1 By Product
      • 11.6.1.1 Software centric medication adherence market, by type
      • 11.6.1.2 Hardware centric medication adherence market, by devices
      • 11.6.1.3 Hardware centric medication adherence market, by packaging
    • 11.6.2 By Medication
  • 11.7 Italy Medication Adherence Market
    • 11.7.1 By Product
      • 11.7.1.1 Software centric medication adherence market, by type
      • 11.7.1.2 Hardware centric medication adherence market, by devices
      • 11.7.1.3 Hardware centric medication adherence market, by packaging
    • 11.7.2 By Medication
  • 11.8 Japan Medication Adherence Market
    • 11.8.1 By Product
      • 11.8.1.1 Software centric medication adherence market, by type
      • 11.8.1.2 Hardware centric medication adherence market, by devices
      • 11.8.1.3 Hardware centric medication adherence market, by packaging
    • 11.8.2 By Medication
  • 11.9 China Medication Adherence Market
    • 11.9.1 By Product
      • 11.9.1.1 Software centric medication adherence market, by type
      • 11.9.1.2 Hardware centric medication adherence market, by devices
      • 11.9.1.3 Hardware centric medication adherence market, by packaging
    • 11.9.2 By Medication
  • 11.10 India Medication Adherence Market
    • 11.10.1 By Product
      • 11.10.1.1 Software centric medication adherence market, by type
      • 11.10.1.2 Hardware centric medication adherence market, by devices
      • 11.10.1.3 Hardware centric medication adherence market, by packaging
    • 11.10.2 By Medication

Chapter 12. Medication Adherence Product Analysis

  • 12.1 Hardware-Centric Products
    • 12.1.1 Philips Automated Medication Dispenser
      • 12.1.1.1 Overview
      • 12.1.1.2 Pros
      • 12.1.1.3 Cons
    • 12.1.2 2net Hub
      • 12.1.2.1 Overview
      • 12.1.2.2 Pros
      • 12.1.2.3 Cons
    • 12.1.3 Omnicell XT
      • 12.1.3.1 Overview
      • 12.1.3.2 Pros
      • 12.1.3.3 Cons
    • 12.1.4 Smart Pill Bottle
      • 12.1.4.1 Overview
      • 12.1.4.2 Pros
      • 12.1.4.3 Cons
    • 12.1.5 Nomi Pill Bottle
      • 12.1.5.1 Overview
      • 12.1.5.2 Pros
      • 12.1.5.3 Cons
    • 12.1.6 Cardinal Health Repackaging Solutions
      • 12.1.6.1 Overview
      • 12.1.6.2 Pros
      • 12.1.6.3 Cons
    • 12.1.7 Dispill
      • 12.1.7.1 Overview
      • 12.1.7.2 Pros
      • 12.1.7.3 Cons
  • 12.2 Software-Centric Products
    • 12.2.1 RelayRx PriorAuthPlus
      • 12.2.1.1 Overview
      • 12.2.1.2 Pros
      • 12.2.1.3 Cons
    • 12.2.2 Adherence Performance Solution
      • 12.2.2.1 Overview
      • 12.2.2.2 Pros
      • 12.2.2.3 Cons
    • 12.2.3 eVoucherRx
      • 12.2.3.1 Overview
      • 12.2.3.2 Pros
      • 12.2.3.3 Cons
    • 12.2.4 RelayRx Continuity of Care
      • 12.2.4.1 Overview
      • 12.2.4.2 Pros
      • 12.2.4.3 Cons
    • 12.2.5 Care4Today
      • 12.2.5.1 Overview
      • 12.2.5.2 Pros
      • 12.2.5.3 Cons
    • 12.2.6 Patient Advisor
      • 12.2.6.1 Overview
      • 12.2.6.2 Pros
      • 12.2.6.3 Cons
    • 12.2.7 2net Mobile and 2net Platform
      • 12.2.7.1 Overview
      • 12.2.7.2 Pros
      • 12.2.7.3 Cons
    • 12.2.8 Pharmacy Health Connect
      • 12.2.8.1 Overview
      • 12.2.8.2 Pros
      • 12.2.8.3 Cons
    • 12.2.9 Prescription Reminder Service - Local Store Marketing
      • 12.2.9.1 Overview
      • 12.2.9.2 Pros
      • 12.2.9.3 Cons
    • 12.2.10 Medication Therapy Management Solution
      • 12.2.10.1 Overview
      • 12.2.10.2 Pros
      • 12.2.10.3 Cons
  • 12.3 Products/Technologies Adopted by Pharmaceutical/ Biopharmaceutical Companies
    • 12.3.1 Smart Pill Bottles, Boxes, and Caps
    • 12.3.2 AI-Based Products
    • 12.3.3 Automation of Directly Observed Therapy (DOT)
    • 12.3.4 Connected Devices
    • 12.3.5 Interactive Software
    • 12.3.6 Smart Injectors
    • 12.3.7 Mobile Applications/Software
  • 12.4 Regional Analysis of Medication Adherence Market
    • 12.4.1 North America
      • 12.4.1.1 Key trends
      • 12.4.1.2 Impact of the healthcare system on the market
      • 12.4.1.3 Forecast analysis
    • 12.4.2 Europe
      • 12.4.2.1 Key trends
      • 12.4.2.2 Impact of the healthcare system on the market
      • 12.4.2.3 Forecast analysis
    • 12.4.3 APAC
      • 12.4.3.1 Key trends
      • 12.4.3.2 Impact of the healthcare system on the market
      • 12.4.3.3 Forecast analysis
    • 12.4.4 LATAM
      • 12.4.4.1 Key trends
      • 12.4.4.2 Impact of the healthcare system on the market
      • 12.4.4.3 Forecast analysis
  • 12.5 Impact of Non-Adherence on Clinical Trials

Chapter 13. Competitive Landscape

  • 13.1 List of Players and Their Offerings
  • 13.2 Market Share Analysis of Key Players
  • 13.3 Competitive Benchmarking of Key Players
  • 13.4 Strategic Developments of Key Players
    • 13.4.1 Product/Service Launches
    • 13.4.2 Partnerships
    • 13.4.3 Investments
    • 13.4.4 Other Developments

Chapter 14. Company Profiles

  • 14.1 Koninklijke Philips N.V.
    • 14.1.1 Business Overview
    • 14.1.2 Product and Service Offerings
    • 14.1.3 Key Financial Summary
  • 14.2 Qualcomm Incorporated
    • 14.2.1 Business Overview
    • 14.2.2 Product and Service Offerings
    • 14.2.3 Key Financial Summary
  • 14.3 AdhereTech Inc.
    • 14.3.1 Business Overview
    • 14.3.2 Product and Service Offerings
  • 14.4 McKesson Corporation
    • 14.4.1 Business Overview
    • 14.4.2 Product and Service Offerings
    • 14.4.3 Key Financial Summary
  • 14.5 Omnicell Inc.
    • 14.5.1 Business Overview
    • 14.5.2 Product and Service Offerings
    • 14.5.3 Key Financial Summary
  • 14.6 SMRxT Inc.
    • 14.6.1 Business Overview
    • 14.6.2 Product and Service Offerings
    • 14.6.3 Strategic Growth Plans
  • 14.7 DrFirst.com Inc.
    • 14.7.1 Business Overview
    • 14.7.2 Product and Service Offerings
  • 14.8 Cardinal Health Inc.
    • 14.8.1 Business Overview
    • 14.8.2 Product and Service Offerings
    • 14.8.3 Key Financial Summary
  • 14.9 Johnson & Johnson Services Inc.
    • 14.9.1 Business Overview
    • 14.9.2 Product and Service Offerings
    • 14.9.3 Key Financial Summary

Chapter 15. Appendix

  • 15.1 Abbreviations
  • 15.2 Sources and References
  • 15.3 Related Reports
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.